171 related articles for article (PubMed ID: 23644659)
1. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.
Ki MK; Jeoung MH; Choi JR; Rho SS; Kwon YG; Shim H; Chung J; Hong HJ; Song BD; Lee S
Oncogene; 2013 Nov; 32(48):5449-57. PubMed ID: 23644659
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S
Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206
[TBL] [Abstract][Full Text] [Related]
3. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.
Jang J; Kim MR; Kim TK; Lee WR; Kim JH; Heo K; Lee S
Sci Rep; 2017 Sep; 7(1):10666. PubMed ID: 28878328
[TBL] [Abstract][Full Text] [Related]
4. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
Mura M; Swain RK; Zhuang X; Vorschmitt H; Reynolds G; Durant S; Beesley JF; Herbert JM; Sheldon H; Andre M; Sanderson S; Glen K; Luu NT; McGettrick HM; Antczak P; Falciani F; Nash GB; Nagy ZS; Bicknell R
Oncogene; 2012 Jan; 31(3):293-305. PubMed ID: 21706054
[TBL] [Abstract][Full Text] [Related]
5. Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.
Noy PJ; Lodhia P; Khan K; Zhuang X; Ward DG; Verissimo AR; Bacon A; Bicknell R
Oncogene; 2015 Nov; 34(47):5821-31. PubMed ID: 25745997
[TBL] [Abstract][Full Text] [Related]
6. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
[TBL] [Abstract][Full Text] [Related]
7. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
[TBL] [Abstract][Full Text] [Related]
9. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
10. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.
Zhuang X; Maione F; Robinson J; Bentley M; Kaul B; Whitworth K; Jumbu N; Jinks E; Bystrom J; Gabriele P; Garibaldi E; Delmastro E; Nagy Z; Gilham D; Giraudo E; Bicknell R; Lee SP
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 33004686
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours.
Robinson J; Whitworth K; Jinks E; Nagy Z; Bicknell R; Lee SP
J Pathol Clin Res; 2020 Oct; 6(4):308-319. PubMed ID: 32696621
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.
Sandoval DR; Gomez Toledo A; Painter CD; Tota EM; Sheikh MO; West AMV; Frank MM; Wells L; Xu D; Bicknell R; Corbett KD; Esko JD
J Biol Chem; 2020 Feb; 295(9):2804-2821. PubMed ID: 31964714
[TBL] [Abstract][Full Text] [Related]
13. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion.
Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG
Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181
[TBL] [Abstract][Full Text] [Related]
14. SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.
Zanivan S; Maione F; Hein MY; Hernández-Fernaud JR; Ostasiewicz P; Giraudo E; Mann M
Mol Cell Proteomics; 2013 Dec; 12(12):3599-611. PubMed ID: 23979707
[TBL] [Abstract][Full Text] [Related]
15. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
Khan KA; McMurray JL; Mohammed F; Bicknell R
FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
[TBL] [Abstract][Full Text] [Related]
16. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.
Krishna Priya S; Kumar K; Hiran KR; Bindhu MR; Nagare RP; Vijaykumar DK; Ganesan TS
Int J Clin Oncol; 2017 Feb; 22(1):107-117. PubMed ID: 27567920
[TBL] [Abstract][Full Text] [Related]
17. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
18. CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker.
Yan L; Li X; Yuan Y
Clinics (Sao Paulo); 2022; 77():100029. PubMed ID: 35576868
[TBL] [Abstract][Full Text] [Related]
19. Group XIV C-type lectins: emerging targets in tumor angiogenesis.
Yee EJ; Vigil I; Sun Y; Torphy RJ; Schulick RD; Zhu Y
Angiogenesis; 2024 May; 27(2):173-192. PubMed ID: 38468017
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD).
Zelensky AN; Gready JE
Proteins; 2003 Aug; 52(3):466-77. PubMed ID: 12866057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
